179.072 articles found

A behavioural evaluation of the potential of nNOS inhibitors to control dyskinesia in animal models of Parkinson's disease

Hirsch T.

· 2012-01-01

Strategic development and physicochemical analysis of oral preparations for unstable drugs

Shabir A.

· 2012-01-01

DOI: 10.48780/publications.aston.ac.uk.00024444

Applied proteomics : using the peripheral proteome to identify a surrogate marker of schizophrenia

Sainz-Fuertes R.

· 2012-01-01

The neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson's disease

Ailane S.

· 2012-01-01

Experiences with people with Parkinson's disease : a qualitative approach

Casey H.

· 2012-01-01

Investigating the presynaptic control of striatal dopamine release

Platt NJ.

· 2012-01-01

Liver growth factor promotes the survival of grafted neural stem cells in a rat model of Parkinson's disease.

Reimers D, Osuna C, Gonzalo-Gobernado R, Herranz AS, Diaz-Gil JJ, Jimenez-Escrig A, Asensio MJ, Miranda C, Rodriguez-Serrano M, Bazan E.

Curr Stem Cell Res Ther · 2012-01-01

DOI: 10.2174/157488812798483421PMID: 21190529

Synaptic vesicle trafficking and Parkinson's disease.

Esposito G, Ana Clara F, Verstreken P.

Dev Neurobiol · 2012-01-01

DOI: 10.1002/dneu.20916PMID: 21563316

The benefit of subthalamic deep brain stimulation for pain in Parkinson disease: a 2-year follow-up study.

Kim HJ, Jeon BS, Lee JY, Paek SH, Kim DG.

Neurosurgery · 2012-01-01

DOI: 10.1227/neu.0b013e3182266664PMID: 21637137

GW0742, a high-affinity PPAR-δ agonist, mediates protection in an organotypic model of spinal cord damage.

Esposito E, Paterniti I, Meli R, Bramanti P, Cuzzocrea S.

Spine (Phila Pa 1976) · 2012-01-01

DOI: 10.1097/brs.0b013e3182276d88PMID: 21685825

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage.

Chen SH, Wu HM, Ossola B, Schendzielorz N, Wilson BC, Chu CH, Chen SL, Wang Q, Zhang D, Qian L, Li X, Hong JS, Lu RB.

Br J Pharmacol · 2012-01-01

DOI: 10.1111/j.1476-5381.2011.01575.xPMID: 21726209

Metabotropic glutamate receptors and interacting proteins: evolving drug targets.

Enz R.

Curr Drug Targets · 2012-01-01

DOI: 10.2174/138945012798868452PMID: 21777188